Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,666 | -129,766 | -106,789 | -71,079 | -34,127 |
| Depreciation Amortization | 693 | 2,866 | 2,143 | 1,376 | 678 |
| Accounts payable and accrued liabilities | 1,045 | -3,011 | 2,056 | 123 | 558 |
| Other Working Capital | 1,109 | -18,178 | -6,357 | -5,998 | -6,384 |
| Other Operating Activity | 1,540 | 12,770 | 5,630 | 4,725 | 1,689 |
| Operating Cash Flow | $-24,279 | $-135,319 | $-103,317 | $-70,853 | $-37,586 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -4,407 | -4,236 | -2,811 | -1,532 |
| Purchase Of Investment | N/A | -87,471 | -87,471 | -87,472 | -60,938 |
| Sale Of Investment | N/A | 201,250 | 186,250 | 152,250 | 76,000 |
| Investing Cash Flow | $-70 | $109,372 | $94,543 | $61,967 | $13,530 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 264 | N/A | 191 | N/A |
| Other Financing Activity | 0 | -600 | -409 | -600 | -525 |
| Financing Cash Flow | $N/A | $-336 | $-409 | $-409 | $-525 |
| Beginning Cash Position | 157,437 | 183,720 | 183,720 | 183,720 | 183,720 |
| End Cash Position | 133,088 | 157,437 | 174,537 | 174,425 | 159,139 |
| Net Cash Flow | $-24,349 | $-26,283 | $-9,183 | $-9,295 | $-24,581 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,279 | -135,319 | -103,317 | -70,853 | -37,586 |
| Capital Expenditure | -70 | -4,407 | -4,236 | -2,811 | -1,532 |
| Free Cash Flow | -24,349 | -139,726 | -107,553 | -73,664 | -39,118 |